Nuwellis Inc
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
NUWE$5.24+6.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (Deficit)
Stockholders’ Equity
(in thousands, except share amounts)
| Outstanding Shares of Common Stock | Common Stock | Additional Paid in Capital | Accumulated Other Comprehensive Income | Accumulated Deficit | Stockholders’ Equity | |
|---|---|---|---|---|---|---|
| Balance December 31, 2022 | 15,326 | $— | $279,736 | $38 | $(267,417) | $12,357 |
| Net loss | — | — | — | — | (6,485) | (6,485) |
| Unrealized foreign currency translation adjustment | — | — | — | (7) | — | (7) |
| Unrealized gain on marketable securities | — | — | — | 6 | — | 6 |
| Stock-based compensation | — | — | 181 | — | — | 181 |
| Issuance costs related to 2022 common stock offering | — | — | (11) | — | — | (11) |
| Conversion of preferred stock into common stock | 300 | — | — | — | — | — |
| Reclassification of warrants to equity | — | — | 7,623 | — | — | 7,623 |
| Conversion of warrants into common stock | 18,858 | — | — | — | — | — |
| Balance March 31, 2023 | 34,484 | $— | $287,529 | $37 | $(273,902) | $13,664 |
| Net loss | — | — | — | — | (4,845) | (4,845) |
| Unrealized gain on marketable securities | — | — | — | (61) | — | (61) |
| Stock-based compensation | — | — | 197 | — | — | 197 |
| Issuance costs related to ATM offering | — | — | (98) | — | — | (98) |
| Issuance of common stock from ATM offering | 18,781 | — | 2,217 | — | — | 2,217 |
| Balance June 30, 2023 | 53,265 | $— | $289,845 | $(24) | $(278,747) | $11,074 |
| Net loss | — | — | — | — | (3,370) | (3,370) |
| Stock-based compensation | — | — | 135 | — | — | 135 |
| Balance September 30, 2023 | 53,265 | $— | $289,980 | $(24) | $(282,117) | $7,839 |
| Outstanding Shares of Common Stock | Common Stock | Additional Paid in Capital | Accumulated Other Comprehensive Income | Accumulated Deficit | Stockholders’ Equity | |
|---|---|---|---|---|---|---|
| Balance December 31, 2023 | 162,356 | $— | $290,647 | $(31) | $(287,626) | $2,990 |
| Net loss | — | — | — | — | (4,330) | (4,330) |
| Unrealized foreign currency translation adjustment | — | — | — | (9) | — | (9) |
| Stock-based compensation, net | — | — | 158 | — | — | 158 |
| Issuance of common stock from conversion of series J convertible preferred stock | 31,971 | — | 1,535 | — | — | 1,535 |
| Series J convertible preferred stock deemed dividend | — | — | 541 | — | — | 541 |
| Balance March 31, 2024 | 194,327 | $— | $292,881 | $(40) | $(291,956) | $885 |
| Net loss | — | — | — | — | (7,725) | (7,725) |
| Unrealized foreign currency translation adjustment | — | — | — | (2) | — | (2) |
| Stock-based compensation, net | — | — | 115 | — | — | 115 |
| Issuance of common stock, net | 321,417 | — | (109) | — | — | (109) |
| Balance June 30, 2024 | 515,744 | $— | $292,887 | $(42) | $(299,681) | $(6,836) |
| Net loss | — | — | — | — | 2,358 | 2,358 |
| Unrealized foreign currency translation adjustment | — | — | — | (4) | — | (4) |
| Stock-based compensation, net | — | — | 101 | — | — | 101 |
| Issuance of common stock net | 952,658 | — | 2,882 | — | — | 2,882 |
| Exercise of common stock warrants | 398,488 | — | 1,182 | — | — | 1,182 |
| Issuance costs | — | — | (722) | — | — | (722) |
| Deemed dividend | — | — | (1) | — | — | (1) |
| Reclassification of April 2024 warrants to equity | — | — | 4,217 | — | — | 4,217 |
| Balance September 30, 2024 | 1,866,890 | $— | $300,546 | $(46) | $(297,323) | $3,177 |
Condensed ConsolidatedStatements of
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.